Financials
- Market Capitalization 22.01 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
15.41
市销率
3.86
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 517 | ROIV Roivant Sciences Ltd. - Common Shares | 33.37 USD | -3.53% | -6.08% | -17.89% | +82.25% | 24.10 B USD | ||
| 524 | UTHR United Therapeutics Corporation - Common Stock | 543.45 USD | -1.21% | +0.34% | +7.26% | +24.15% | 23.31 B USD | ||
| 547 | BNTX BioNTech SE - American Depositary Shares | 89.00 USD | -7.14% | -7.03% | -12.75% | -12.27% | 21.36 B USD | ||
| 559 | INSM Insmed Incorporated - Common Stock | 96.78 USD | -1.81% | -8.03% | -25.27% | -40.28% | 21.13 B USD |